Canton Strategic Holdings, Inc. Common Stock is a pharmaceutical preparations company trading on XNAS, led by CEO Mark Wendland, with a market cap of $163.3M.
Common questions about Canton Strategic Holdings, Inc. Common Stock
Canton Strategic Holdings, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 11, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.